Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer with Dr. Yee - 100280

Spotlight
Video

Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer with Dr. Yee

onclivetv has 407 videos Subscribe Here

Loading........
Description: Dr. Yee discusses the research that led to the FDA approval of neoadjuvant pertuzumab as part of a combination regimen for patients with HER2-positive breast cancer.
Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota,
Shared By : onclivetv
Posted on : 08/10/15
Added : 3 years ago
Category : Breast Cancer